Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL | NASDAQ
Chart Builder DCF Calculator
$2.40
-$0.02 (-0.83%)
At close: Sep 21, 2026, 4:00 PM ET
$2.43
+$0.03 (+1.25%)
Pre-market: Sep 22, 2026, 4:00 AM ET
Fiscal Quarter
Period Ending
Q3 2026
Jun 29, 2026
Q2 2026
Mar 30, 2026
Q1 2026
Dec 30, 2025
Q4 2025
Sep 29, 2025
Q3 2025
Jun 29, 2025
Q2 2025
Mar 30, 2025
Q1 2025
Dec 30, 2024
Q4 2024
Sep 29, 2024
Q3 2024
Jun 29, 2024
Q2 2024
Mar 30, 2024
Q1 2024
Dec 30, 2023
Q4 2023
Sep 29, 2023
Q3 2023
Jun 29, 2023
Q2 2023
Mar 30, 2023
Q1 2023
Dec 30, 2022
Q4 2022
Sep 29, 2022
Q3 2022
Jun 29, 2022
Q2 2022
Mar 30, 2022
Q1 2022
Dec 30, 2021
Q4 2021
Sep 29, 2021
Q3 2021
Jun 29, 2021
Q2 2021
Mar 30, 2021
Q1 2021
Dec 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-6.53M -6.48M -6.78M -10.84M -14.46M -12.51M -13.59M -14.34M -14.6M -12.62M -11.38M -12.65M -13.53M -14.19M -15.36M -15.28M -12.46M -11.52M -11.72M -12.25M -11.36M -8.94M -9.4M
Interest Income
n/a 1.06M 1.08M 999K 1.08M 1.21M 1.39M 1.76M 1.8M 1.76M 2.01M 1.96M 1.83M 1.47M 1.27M 704.58K 229.92K 7.58K 4.91K 7.15K 11.45K 9.22K n/a
Pretax Income
-3.18M -5.37M -5.66M -9.83M -13.24M -11.2M -12.11M -11.74M -12.21M -10.55M -8.62M -10.21M -11.24M -13.06M -12.99M -14.08M -12.28M -10.41M -10.85M -11.58M -10.14M -8.13M -7.8M
Net Income
-3.2M -5.34M -5.68M -9.83M -13.24M -11.2M -12.11M -11.62M -12.21M -10.55M -8.62M -10.15M -11.28M -13.11M -12.97M -14.29M -12.37M -10.44M -10.88M -11.72M -10.18M -8.16M -7.86M
Selling & General & Admin
2.39M 2.29M 2.13M 3.55M 4.5M 2.62M 3.15M 2.78M 2.79M 2.9M 2.69M 2.59M 3.25M 2.88M 3.32M 3.9M 3.19M 2.92M 3.07M 2.88M 2.43M 2.23M 1.47M
Research & Development
4.14M 4.19M 4.66M 7.29M 9.96M 9.89M 10.45M 11.56M 11.81M 9.73M 8.68M 10.06M 10.28M 10.56M 12.07M 11.38M 9.27M 8.6M 8.66M 9.37M 8.96M 6.72M 7.93M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 750K -25K n/a n/a n/a n/a n/a -43.28K -10.82K n/a
Operating Expenses
6.53M 6.48M 6.78M 10.84M 14.46M 12.51M 13.59M 14.34M 14.6M 12.62M 11.38M 12.65M 13.53M 14.19M 15.36M 15.28M 12.46M 11.52M 11.72M 12.25M 11.36M 8.94M 9.4M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 964K n/a n/a n/a n/a n/a n/a n/a n/a 1.56K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.53M 6.48M 6.78M 10.84M 14.46M 12.51M 13.59M 14.34M 14.6M 12.62M 11.38M 12.65M 13.53M 14.19M 15.36M 15.28M 12.46M 11.52M 11.72M 12.25M 11.36M 8.94M 9.4M
Income Tax Expense
18K -27K 18K n/a n/a n/a n/a -124K n/a n/a n/a -63.95K 41K 50K -20K 210.29K 88.42K 29.8K 29.98K 142.3K 39K 26.99K 59.28K
Shares Outstanding (Basic)
91.45M 92.68M 89.03M 85.89M 85.38M 85.07M 84.81M 84M 84.54M 82.46M 82.08M 79.79M 80.88M 78.3M 77.98M 76.91M 77.44M 76.25M 76M 75.78M 70.59M 68.6M 64.3M
Shares Outstanding (Diluted)
91.45M 92.68M 89.03M 85.89M 85.38M 85.07M 84.81M 84M 84.54M 82.46M 82.08M 79.79M 80.88M 78.3M 77.98M 76.91M 77.44M 76.25M 76M 76M 70.59M 68.6M 64.3M
EPS (Basic)
-0.03 -0.06 -0.06 -0.11 -0.16 -0.13 -0.14 -0.14 -0.14 -0.13 -0.10 -0.13 -0.14 -0.17 -0.17 -0.19 -0.16 -0.14 -0.14 -0.15 -0.14 -0.12 -0.12
EPS (Diluted)
-0.03 -0.06 -0.06 -0.11 -0.16 -0.13 -0.14 -0.14 -0.14 -0.13 -0.10 -0.13 -0.14 -0.17 -0.17 -0.19 -0.16 -0.14 -0.14 -0.15 -0.14 -0.12 -0.12
EBITDA
-3.18M -6.48M -5.66M -6.49M -14.31M -12.42M -13.58M -11.74M -14.08M -12.15M -8.62M -10.21M -11.24M -12.09M -12.99M -14.08M -12.28M -10.41M -10.85M -11.58M -10.14M -8.94M n/a
EBIT
-3.18M -6.48M -5.66M -6.49M -14.31M -12.42M -13.58M -11.74M -14.08M -12.15M -8.62M -10.21M -11.24M -12.09M -12.99M -14.08M -12.28M -10.41M -10.85M -11.58M -10.14M -8.94M -8.13M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.13M

© 2026 bestshares.com. All rights reserved.